Systematic review of influenza A(H1N1)pdm09 virus shedding: Duration is affected by severity, but not age

Influenza and other Respiratory Viruses

Volumn 8, Issue 2, 2014, Pages 142-150

  Fielding, James E ^a,b   Kelly, Heath A ^a,b   Mercer, Geoffry N ^a,b   Glass, Kathryn ^b  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b The Australian National University   (Australia)

Author keywords

Adult; Antiviral agents; Child; Influenza A virus, H1N1 subtype; Influenza, human; Virus shedding

Indexed keywords

ADULT; ANTIVIRAL AGENTS; CHILD; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; VIRUS SHEDDING;

AGE FACTORS; ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VIRUS SHEDDING;

EID: 84894489574     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12216     Document Type: Review

References (50)

1. Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics-implications for policy. N Engl J Med 2009; 360:2595-2598.
2. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006; 12:9-14.
3. Australian Government Department of Health and Ageing. Australian Health Management Plan for Pandemic Influenza. Available at http://www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/8435EDE93CB6FCB8CA2573D700128ACA/$File/Pandemic%20FINAL%20webready.pdf (Accessed 31 May 2013).
4. Smith GJ, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459:1122-1125.
5. Grant KA, Fielding JE, Mercer GN et al. Comparison of the pandemic H1N1 2009 experience in the southern hemisphere with pandemic expectations. Aust N Z J Public Health 2012; 36:364-368.
6. World Health Organization. Pandemic influenza preparedness and response: a WHO guidance document. Available at http://whqlibdoc.who.int/publications/2009/9789241547680_eng.pdf (Accessed 31 May 2013).
7. Bell DM. Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006; 12:88-94.
8. Carrat F, Vergu E, Ferguson NM et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775-785.
9. Suess T, Buchholz U, Dupke S et al. Shedding and transmission of novel influenza virus A/H1N1 infection in households-Germany, 2009. Am J Epidemiol 2010; 171:1157-1164.
10. Cowling BJ, Chan KH, Fang VJ et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-2184.
11. Xiao H, Lu SH, Ou Q, Chen YY, Huang SP. Hospitalized patients with novel influenza A (H1N1) virus infection: Shanghai, June - July 2009. Chin Med J 2010; 123:401-405.
12. Hien TT, Boni MF, Bryant JE et al. Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Med 2010; 7:e1000277.
13. Suryaprasad A, Morgan OW, Peebles P et al. Virus detection and duration of illness among patients with 2009 pandemic influenza A (H1N1) virus infection in Texas. Clin Infect Dis 2011; 52(Suppl 1):S109-S115.
14. Leung YH, Lim WL, Wong MH, Chuang SK. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect 2012; 140:814-817.
15. Loeb M, Singh PK, Fox J et al. Longitudinal study of influenza molecular viral shedding in Hutterite communities. J Infect Dis 2012; 206:1078-1084.
16. Meschi S, Selleri M, Lalle E et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis 2011; 11:140.
17. Kay M, Zerr DM, Englund JA et al. Shedding of pandemic (H1N1) 2009 virus among health care personnel, Seattle, Washington, USA. Emerg Infect Dis 2011; 17:639-644.
18. Killingley B, Greatorex J, Cauchemez S et al. Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings. Health Technol Assess 2010; 14:237-354.
19. Bhattarai A, Villanueva J, Palekar RS et al. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak-Pennsylvania, May-June 2009. Clin Infect Dis 2011; 52(Suppl 1):S102-S108.
20. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981; 144:433-441.
21. Hall CB, Douglas RG Jr, Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis 1979; 140:610-613.
22. Sato M, Hosoya M, Kato K, Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005; 24:931-932.
23. Treanor JJ. Influenza viruses, including avian influenza and swine influenza; in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, 7th ed. Philadelphia: Churchill Livingstone Elsevier, 2010; 2265-2288.
24. Kawai N, Ikematsu H, Iwaki N et al. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation. J Infect Chemother 2012; 18:180-186.
25. Li CC, Wang L, Eng HL et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis 2010; 16:1265-1272.
26. Suess T, Remschmidt C, Schink SB et al. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PLoS ONE 2012; 7:e51653.
27. De Serres G, Rouleau I, Hamelin ME et al. Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:783-788.
28. Fabbiani M, Sali M, Di Cristo V et al. Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy. J Med Virol 2011; 83:2057-2065.
29. Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
30. Fleury H, Burrel S, Balick WeberC et al. Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009. Euro Surveill 2009; 14: pii: 19434.
31. Rodrigues RS, Marchiori E, Bozza FA et al. Chest computed tomography findings in severe influenza pneumonia occurring in neutropenic cancer patients. Clinics 2012; 67:313-318.
32. Souza TM, Salluh JI, Bozza FA et al. H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS ONE 2010; 5:e14158.
33. Tran D, Science M, Dix D et al. Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients. Influenza Other Respi Viruses 2012; 6:e105-e113.
34. Hayden FG, Treanor JJ, Fritz RS et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999; 282:1240-1246.
35. Wu UI, Wang JT, Chen YC, Chang SC. Severity of pandemic H1N1 2009 influenza virus infection may not be directly correlated with initial viral load in upper respiratory tract. Influenza Other Respi Viruses 2012; 6:367-373.
36. Giannella M, Alonso M, Garcia de Viedma D et al. Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect 2011; 17:1160-1165.
37. Li IW, Hung IF, To KK et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137:759-768.
38. Cheng PK, Wong KK, Mak GC et al. Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load. J Clin Virol 2010; 47:182-185.
39. World Health Organization. WHO public health research agenda for influenza. Available at http://www.who.int/influenza/resources/research/2010_04_29_global_influenza_research_agenda_version_01_en.pdf (Accessed 31 May 2013).
40. Beutel G, Wiesner O, Eder M et al. Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care 2011; 15:R80.
41. Cao B, Li XW, Mao Y et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361:2507-2517.
42. Chin BS, Chae YT, Choi HK et al. Viral shedding of 2009 pandemic H1N1 and evaluation of quarantine recommendations. Jpn J Infect Dis 2012; 65:105-110.
43. Duan ZP, Jia ZH, Zhang J et al. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial. Chin Med J 2011; 124:2925-2933.
44. Esposito S, Daleno C, Baldanti F et al. Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus. Virol J 2011; 8:349.
45. Jia N, Gao Y, Suo JJ et al. Viral shedding in Chinese young adults with mild 2009 H1N1 influenza. Chin Med J 2011; 124:1576-1579.
46. Ling LM, Chow AL, Lye DC et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50:963-969.
47. Malato L, Llavador V, Marmier E et al. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010. Euro Surveill 2011; 16: pii: 19776.
48. Petersen E, Keld DB, Ellermann-Eriksen S et al. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v. Scand J Infect Dis 2011; 43:495-503.
49. To KK, Chan KH, Li IW et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 2010; 82:1-7.
50. Waiboci LW, Lebo E, Williamson JM et al. Viral shedding in patients infected with pandemic influenza A (H1N1) virus in Kenya, 2009. PLoS ONE 2011; 6:e20320.